Skip to main content
. 2020 Apr 24;22(8):1073–1113. doi: 10.1093/neuonc/noaa106

Figure 13.

Figure 13.

Challenges to effectively treat GBM include (top) the presence of the blood–brain barrier that precludes the delivery of many drugs into the brain coupled to (middle) an immunosuppressive microenvironment and (bottom) compensatory signaling networks that can render GBM therapies ineffective.